Home
PODCAST
TOP INDUSTRY NEWS
-
Thermo Fisher To Acquire Sterile Mfg Site from Sanofi
-
Kenvue, Former J&J Consumer Health Care Business, Announces CEO Transition
-
Gene Therapy Company Sarepta Therapeutics Restructuring; Cutting One-Third of Workforce
-
Supplier News: Bora, PCI, Fareva & More
-
Mfg News: Amphastar, Ultragenyx, Cellular Origins & More
-
The Next Round in the EU–US Tariff Battle: What’s the Impact on API Supply?
Facing a potential US tariff of 30% coming due on August 1, European Union leaders are mapping out a trade strategy. What’s the impact on pharmaceutical supply chains?
-
The Top 25 Supply Chain Organizations: Where Does Pharma Rank?
Five bio/pharma companies placed in the Gartner Supply Chain Top 25, an annual ranking of the top supply chain organizations. Who ranks at the top?
-
CDMOs/CMOs & Tariffs: The Next Move
The White House extended the deadline to impose reciprocal tariffs on most countries until August 1st. What is the impact on manufacturing & supply lines, and what may be next?
DCAT MEMBER COMPANY COMMUNITY
-
DCAT Awards Grants To Student Scientists at the 2025 Regeneron International Science & Engineering Fair
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of four projects who participated in the Regeneron International Science & Engineering Fair (Regeneron…
-
ICYMI: DCAT Production to Prescription Podcast: “Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?”
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, a key…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
-
New Podcast Episode! Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies)? Is there too much capacity or is the market tight? The latest episode of…
